tradmap

INTT INTEST CORP

$13.91 -2.90%

Data as of close

Healthcare · Instruments For Meas & Testing Of Electricity & Elec Signals

INTEST CORP (INTT) is a healthcare company in the Instruments For Meas & Testing Of Electricity & Elec Signals industry, with a market capitalization of $175 million. Shares last traded at $13.91, 30.6% below their 52-week high. Over the past year the stock is up 62.9%. INTT trades at a price-to-earnings ratio of 295.73, above the Instruments For Meas & Testing Of Electricity & Elec Signals median of 50.03. Net profit margin is 0.5%, below the peer median of 2.6%. Revenue declined 12.9% year over year.

Market Cap
$175M
Shares Out
12.6M
EPS (TTM)
$0.04
P/E (TTM)*
295.73
P/S Ratio
1.44
P/B Ratio
1.67
Dividend / Share
—
Dividend Yield
—
52-Week High
$20.04
52-Week Low
$7.14
Volume (venue)
5,004
Avg Vol (3m, venue)
6,060.46

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-2.52%
1M
+12.63%
3M
-3.40%
6M
-24.48%
YTD
+87.72%
1Y
+62.88%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
51.05
SMA (50)
$12.51
SMA (200)
$13.88
Price vs SMA50
+11.21%
Price vs SMA200
+0.20%
ATR (14)
$0.87

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$121M
Net Income
$591000
Gross Margin
44.0%
Operating Margin
0.1%
Net Margin
0.5%
Return on Equity
0.6%
Return on Assets
0.4%
Current Ratio
2.22
Debt / Equity
0.01
Revenue Growth (YoY)
-12.9%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-03-31. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $0.06 2026-05-11
Q4 2025 (derived) $0.10 2026-03-12
FY 2025 -$0.21 2026-03-12
Q3 2025 -$0.08 2025-11-06
Q2 2025 -$0.04 2025-08-07
Q1 2025 -$0.19 2025-05-08

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Instruments For Meas & Testing Of Electricity & Elec Signals peers

INTT vs 10 industry peers (Instruments For Meas & Testing Of Electricity & Elec Signals), by market cap. Data as of close

P/E vs peers
295.73 / 50.03 med
+491% premium
P/S vs peers
1.44 / 3.26 med
-56% discount
Net margin vs peers
0.5% / 2.6% med
below median
1–10 of 10
TERTeradyne$40.7B29.668.1427.5%-4.82%
VLTOVeralto$28.1B28.084.8517.3%+4.18%
ITRIItron, Inc.$4.4B15.641.8912.1%+4.01%
COHUCohu Inc$2.3B—4.02-4.0%-4.89%
AEHRAehr Test Systems$1.9B—38.66-14.3%+8.04%
ALNTAllient Inc$1.4B50.032.495.0%-1.55%
TRNSTranscat Inc$822M152.832.361.5%+1.73%
FEIMFREQUENCY ELECTRONICS INC$740M276.3010.163.7%-3.26%
INTTINTEST CORP$175M295.731.440.5%-2.90%
DAIODATA I/O CORP$24M—1.37-50.1%-1.67%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.